Plain-English translation of NCT06235151 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a new imaging scan called PET/CT can accurately find prostate cancer that may have spread to lymph nodes before surgery. The medication uses a radioactive tracer that attaches to cancer cells, making them visible on the scan. This helps doctors see exactly where the cancer is located before you have surgery to remove your prostate.
Currently, doctors use standard imaging tests that don't always catch prostate cancer that has spread to nearby lymph nodes. This trial is testing whether this new medication and imaging approach can find cancer more reliably, which could help your doctors plan the best surgery for you.
You likely qualify if…
You likely don't qualify if…
You would receive an injection of the radioactive medication, then wait 1 to 4 hours for it to travel through your body and attach to any cancer cells. After that waiting period, you would have a PET/CT scan (a specialized imaging test) that takes images of your body to find where the cancer is located. The scan itself typically takes 20–30 minutes. Three independent doctors would review your images to look for signs of cancer spread. This all happens before your planned surgery.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States